Noninvasive cardiorespiratory signals analysis for asthma evolution monitoring in preschool children by Milagro, Javier et al.
1
Noninvasive Cardiorespiratory Signals Analysis for
Asthma Evolution Monitoring in Preschool Children
Javier Milagro, Javier Gracia, Ville-Pekka Seppä, Jussi Karjalainen,
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Abstract—Despite its increasing prevalence, diagnosis of
asthma in children remains problematic due to their difficulties
in producing repeatable spirometric maneuvers. Moreover, low
adherence to inhaled corticosteroids (ICS) treatment could result
in permanent airway remodeling. The growing interest in a
noninvasive and objective way for monitoring asthma, together
with the apparent role of autonomic nervous system (ANS) in its
pathogenesis, have attracted interest towards heart rate variabil-
ity (HRV) and cardiorespiratory coupling (CRC) analyses. In this
work, HRV and CRC were analyzed in 70 children who were
prescribed ICS treatment due to obstructive bronchitis. They
underwent three different electrocardiogram and respiratory
signals recordings, during and after treatment period. After
treatment completion, they were followed up during 6 months and
classified attending to their current asthma status. Vagal activity,
as measured from HRV, and CRC, were reduced after treatment
in those children at lower risk of asthma, whereas it kept
unchanged in those with a worse prognosis. Results suggest that
HRV analysis could be useful for the continuous monitoring of
ANS anomalies present in asthma, thus contributing to evaluate
the evolution of the disease, which is especially challenging in
young children.
Index Terms—asthma, heart rate variability, children, inhaled
corticosteroids, obstructive bronchitis.
I. INTRODUCTION
RESPIRATORY tract function assessment remains essen-tial for the diagnosis and monitoring of several respira-
tory affections such as chronic obstructive pulmonary disease
or asthma. Whereas in the former pulmonary function is
permanently reduced, asthma is characterized by a variable
and irregular respiratory tract obstruction, and therefore a
continuous monitoring of airway function would be desirable
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in asthmatics. Yet, assessment of asthma is performed through
the evaluation of the clinical history and single-time airway
function measurements, being spirometry the most extended
test. However, although children as young as 5 years old can
perform acceptable tests, most infants and younger children
are not able to conduct repeatable expiratory maneuvers, since
they remain very effort dependent and require cooperation
[1]. Although there are studies suggesting that children can
generate acceptable flow-volume curves from an age of 3
years [2], [3], measurement criteria are to be standardized,
as differences in the relative size of airways and lungs with
respect to adults make the most common measurements un-
suitable for this population [3], [4]. Moreover, the training
of those children for performing the maneuvers is time-
consuming. Other lung function testing methods such as rapid
thoracoabdominal compression (RTC) and raised volume RTC
have been found to discriminate between health and disease
[5], [6], although reference values are not yet available to be
used in clinical settings [7]. For these reasons, diagnosis of
asthma in young children is very dependent on the clinical
history, which is retrospective in nature and could be even
incomplete.
Treatment of asthma during childhood is equally challeng-
ing, and although inhaled corticosteroids (ICS) remain the
standard medication for the prevention of symptoms, there
is some controversy regarding the possible negative effects
that ICS may have during childhood, namely growth reduction
during the first weeks of treatment, or hypothalamic-pituitary-
adrenal (HPA) axis suppression [8]–[10]. This, together with
the low perceived risk, have contributed to a low adherence to
asthma treatment [11]. However, early intervention is crucial,
since lung function increases up to 20-fold during the first 10
years of life [12], so that absence of treatment when needed
could lead to permanent airway remodeling [13]. In this way,
a proper monitoring of the symptoms is needed in order to
decide whether continuing or interrupting the ICS treatment.
These difficulties in the diagnosis, monitoring and treatment
of asthma during childhood have motivated several studies
aiming at developing a non-invasive tool that can be used for
patient state assessment in a time-continuous manner. Most
of them have focused on autonomic nervous system (ANS)
monitoring, since abnormal ANS activity has been related
with the pathogenesis of asthma [14], [15]. Particularly, the
parasympathetic branch of the ANS is involved in broncho-
constriction [16] and bronchomotor tone control [17], and
the fact that sympathetic innervation is sparse in the small
airways [16] has pointed to parasympathetic nervous system
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(PNS) as strongly related with altered airway tone in asth-
matics. Apart from the respiratory system, ANS activity also
modulates cardiac activity. Thus, heart rate variability (HRV)
analysis is acknowledged as a convenient tool for ANS activity
assessment, and has been employed for its characterization
in asthma, both in adults [18], [19] and children [15], [20].
Given the close existing relationship between HRV and res-
piration control, cardiorespiratory coupling (CRC) has also
been suggested to be altered in some respiratory disorders
[21], although to the best of our knowledge it has not been
studied in asthma. Hence, the present study aims at assessing
the possible clinical value of HRV and CRC analysis in the
monitoring of asthma/risk of asthma evolution in children
under and after ICS treatment. Since results of previous studies
using HRV analysis for asthma severity/risk assessment in
children suggest increased [15] and more regular [20], [22]
PNS activity in subjects with worse outcomes, it is expectable
that PNS activity will turn normal after treatment in subjects
without or with low risk of asthma, but it should remain
unchanged in children with or at high risk of asthma.
II. MATERIALS AND METHODS
A. Study population
The dataset employed in this study is composed of 70
children aged 2.5 (0.9-5.7) years old (median and range) who
visited the Tampere University Hospital emergency room due
to obstructive bronchitis. All of them were prescribed ICS
treatment for three months. ECG and impedance pneumogra-
phy (IP) were acquired at a sampling rate of 256 Hz with
a custom designed recording device developed at Tampere
University [23]. Three different recordings were scheduled for
each subject:
• Recording 1 (R1) was scheduled 1 week before the end of
the ICS treatment. It started at the clinic, where the par-
ents were instructed how to place the electrodes and start
and pause the biosignals acquisition, and lasted until the
next morning, when parents stopped the measurement.
• Recording 2 (R2) was conducted 1-2 weeks after the
end of the treatment and was performed at home, solely
by the parents. In order to ensure the validity of the
recordings, the parents were requested to take pictures
of the electrodes placement. The recording started along
the evening, and lasted until the children woke up in the
morning.
• Recording 3 (R3) was scheduled 3-4 weeks after the end
of the treatment and, as in R2, it was conducted by the
parents, who were asked to take pictures of the electrodes
position and to start the recording during the evening and
to finish it in the next morning.
Additionally, parents were requested to annotate the times
when children fall asleep and woke up in the morning.
Patients were followed up during a period of 6 months
after R3 by a pediatric pulmonologist, in order to determine
their current asthma (CA) status. They were labeled as having
current asthma (CA-Y) if they had been prescribed medication
for the control of asthma in that period because of wheezing
evidence, or reported nocturnal or exercise-induced shortness
Fig. 1. Distribution of the subjects attending to the three different classifica-
tions. In the figure, CA-N, CA-P and CA-Y refer to the current asthma status
(CA-N: no current asthma, CA-P: possible current asthma, CA-Y: current
asthma), whereas T-N, T-P and T-E refer to the response to ICS treatment
(T-N: not effective, T-P: partially effective, T-E: effective). This information
was not available for 4 of the 70 subjects.
of breath or cough which were reversible with bronchodilator
medication. Patients who did not meet the previous criteria
but were intermittently prescribed the medication because
of symptoms of asthma were labeled as showing possible
current asthma (CA-P), whereas all the remaining patients
were labeled as showing absence of current asthma (CA-N).
Patients were also classified depending on their atopic status,
measured through a skin prick test (SPT). The responses to
the SPT were considered positive when at least one of the
assessed allergens (egg, cat, dog, birch and timothy) caused a
wheel with a diameter greater than or equal to 3 mm without
showing reaction to a negative control substance. Patients were
classified as atopics or non-atopics if showing a positive or
negative response to the SPT, respectively. Furthermore, they
were classified based on their response to ICS treatment as
effective, partially effective or not effective. The classification
of the subjects attending to the different criteria is summarized
in Fig. 1. Signals and/or classification criteria were absent for
3 of the 70 subjects. Additionally, atopic condition was not
available for one subject.
None of the subjects had previous history of laryngeal
disease, tracheobronchial malacia, parechymal lung disease or
bronchopulmonary displasia (all these conditions could affect
the accuracy of the IP recording). Written informed consent
was received from the parents of all the children.
B. Preprocessing
Only data recorded when the children were asleep (ac-
cording to parents annotations) were analyzed, since vagal
modulation of cardiac activity [24] and bronchoconstriction
[25] are increased during night, together with a reduction in
airway function which is specially noticeable in asthmatics
[25], [26].
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Preprocessing was very similar to that proposed in our
previous work [20]. First, ECG signals were resampled at 1000
Hz with linear interpolation, so that the effect of sampling
frequency on HRV analysis was reduced [27]. Afterwards,
baseline wander was corrected by subtracting the ECG base-
line (extracted with low-pass filtering with 0.5 Hz cut-off
frequency) from the interpolated signals. For R-peak detection,
the wavelet-based approach described by Martı́nez et al. [28]
was employed, and the method proposed by Mateo and La-
guna [29] was used for ectopic beats detection and correction.
However, ectopic beats are not very frequent in young children
[30], [31], so it is important to distinguish their effect from the
effect of respiratory sinus arrhythmia (RSA) episodes, which
are stronger for children than for adults [32]. In this way, when
a beat was classified as ectopic, the following condition was
checked:
θ · RRe ≥ RRe-1, (1)
being RRe the time interval between the beat classified as
ectopic and the previous one, RRe-1 the time interval between
the beat previous to the ectopic and the previous one and θ a
given threshold [20]. If the condition in Eq. 1 was satisfied,
the analyzed inter-beat interval was considered to be produced
by strong RSA, and the beat was not classified as an ectopic.
In this work, θ was selected as 1.5, being it adjusted manually
for 6 subjects.
On the other hand, IP recordings were downsampled at 4
Hz, and band-pass filtered (cut-off frequencies of 0.05 and 0.5
Hz) so that the baseline and other components unrelated with
respiration were discarded. Respiratory rate, Fr, was estimated
from the IP signals in a time-continuous basis, according to
the method proposed by Lázaro et al. [33].
In order to avoid noisy signal segments (probably movement
artifacts) that could compromise the analysis, signal to noise
ratio (SNR) was evaluated beat by beat, as described by Bailón
et al. [34]. Beats with a SNR more than 20 dB below the
median SNR of the whole night recording were labeled as
“low quality”. If “low quality” beats were found during more
than 3 consecutive seconds, this segment was considered noisy
and discarded from the analysis.
C. Heart rate variability analysis
Time and frequency domain HRV analyses were considered,
and they were performed in five-minute windows, with four-
minute overlap. For the time domain analysis, mean normal-
to-normal interval (NN), SDNN, SDSD, RMSSD and pNN50
were derived from the RR interval series after ectopic cor-
rection, as suggested by the Task Force [35]. For frequency
domain analysis, the time-varying integral pulse frequency
modulation (TVIPFM) model was employed for estimating
the modulating signal, m(t), which represents the autonomic
modulation of the heart rate (HR) [36]. Essentially, the mod-





where dHR(t) stands for the instantaneous HR signal obtained
from the TVIPFM model and dHRM(t) is a low-pass filtered
version (0.03 Hz cut-off frequency) of dHR(t). The signal m(t)
was finally resampled at 4 Hz.
Welch’s periodogram (50-second Hamming windows, 50%
overlap) was applied to m(t) for estimating the HRV power
spectral density corresponding to the k-th five-minute window
window, ŜHRV(k, F ), and the resulting spectra were employed
for frequency domain HRV analysis. Low-frequency (LF) and
high-frequency (HF) power (PLF(k) and PHF(k) respectively)
were calculated from each segment. Whereas the former was
obtained as the power within the classical [0.04, 0.15] Hz LF
band [35], the frequency band used in the computation of the
latter was redefined. In this way, instead of the classical [0.15,
0.4] Hz HF band, a 0.15 Hz bandwidth centered in the mean
respiratory rate of each segment was employed [20]. The use
of a modified HF band was encouraged by the increased Fr
observed in children, with values close to the upper limit of
the classical HF band that could lead to an underestimation
of PHF due to a shift of power towards frequencies higher
than 0.4 Hz. PLF to PHF ratio (RLF/HF(k) = PLF(k)/PHF(k)) and
normalized LF power (PLFn(k) = PLF(k)/(PLF(k) + PHF(k)))
were also considered.
Finally, another spectral parameter, named peakness (℘),
was computed. It was already used in a previous work for the
characterization of a population of children classified attending
to their risk of developing asthma [20]. Basically, it accounts
for the distribution of the HF components of HRV around the









where ∆f is 0.026 Hz (resolution of the Hamming window),
∆F is the 0.15 Hz frequency window employed in the
definition of the HF band, and Fr(k) and HR(k) are the
mean Fr and HR in the k-th five-minute window respectively
(the upper limit of HR(k)/2 was used since HR remains the
intrinsic sampling frequency of HRV [37]). In this way, the
value of ℘ will be closer to 1 as the HF components are more
concentrated around Fr.
D. Time-Frequency Coherence Analysis
The time-frequency (TF) cross-spectrum of the HRV and the
IP signals, ŜHRV,IP(t, f), was estimated using a TF distribution







where AHRV,IP(ν, τ) is the ambiguity function [39] of the analyt-
ical signal representation of the modulating and the IP signals,
xHRV(t) and xIP(t), obtained using the Hilbert transform. On the
other hand, Φ(ν, τ) is a smoothing function in the ambiguity
domain (in this work it was selected as an elliptic exponential


























The time and frequency resolution of ŜHRV,IP(t, f) can be
adjusted by modifying the shape of the smoothing kernel in
Eq. 5 through the parameters ν0 and τ0, respectively. Also the
roll-off factor of the kernel can be controlled with λ. In this
work, these parameters were fixed to ν0 = 0.045, τ0 = 0.05
and λ = 0.3, as in [40], yielding to a time and frequency
resolution of 11.25 s and 0.039 Hz respectively (time and
frequency resolution were calculated as the full width at half
maximum of the TF distribution of a Dirac impulse evaluated
along t, and of a pure sinusoid evaluated along f ). Afterwards,






where ŜHRV(t, f) and ŜIP(t, f) represent the TF spectra of the
modulating and the IP signals respectively, estimated as in Eq.
4. Finally, two different parameters were proposed as CRC
measurements. The first one consists in the bandwidth Ω(t),
in which both spectra are considered coherent for each time
instant t, i.e., the bandwidth for which γ̂2(t, f) ≥ γTH(t, f ;α),
being γTH(t, f ;α) the signal-independent threshold defined in
[38], with α = 0.01. An example of the calculation of Ω is
displayed in Fig. 2. Moreover, the mean coherence in Ω(t),
γ̂2
Ω









being Ω1(t) and Ω2(t) the lower and upper limits of the
frequency band for which γ̂2(t, f) ≥ γTH(t, f ;α) in the time
instant t.
E. Statistical analysis
Median of each parameter was obtained from two-hour
windows, so that at least one complete sleep cycle is covered
[41] and the effect of sleep stages is hence minimized. A
two-hour median was calculated every hour from 23:00 p.m.
to 06:00 a.m., thus resulting in 8 windows per parameter,
subject and recording day. Afterwards, the differences in the
groups classified attending to the current asthma status, atopy
and response to treatment were assessed by comparing each
two-hour median of each subject along the three recording
days, using a paired Wilcoxon signed-rank test. In all the
tests, p < 0.05 was set as the significance level to consider
statistical differences. When subjects were classified in more
than 2 groups, Bonferroni correction was applied.
III. RESULTS
Since children were labeled attending to their current asthma



































































Fig. 2. A five-minute segment of the normalized time-frequency distribution
of the heart rate modulating signal (a)) and the impedance pneumography
signal (b)) are displayed. In c), the time-frequency coherence distribution
is depicted. The black dotted lines represent the limits between which
γ̂2(t, f) ≥ γTH(t, f ;α), defining Ω(t) (see text for details).
the analysis were evaluated considering each of these clas-
sifications independently. The greatest amount of significant
differences was obtained for the HRV indexes accounting
for parasympathetic activity and the CRC parameters so, for
simplicity, only they were considered below. From all the
available subjects, there were 5 with the 3 recordings absent
or discarded due to bad quality, and also 10 for which 2 out
of 3 recordings were not considered for the same reasons.
Since inter-day behavior of the different parameters followed
a similar tendency along the night, results obtained at the hour
with the greatest amount of significant differences, i.e., at 04
a.m., are summarized in Tables I and II.
Attending to current asthma status: A clear tendency
towards increased PLFn and decreased RMSSD, PHF and ℘
was found in R3 with respect to R1 and R2 in CA-N. This
behavior was consistent along several parameters and two-
hour windows, as displayed in Fig. 3. These differences were
specially noticeable at 03 and 04 a.m. in the frequency-
domain HRV indexes. A similar behavior was assessed in the
CRC parameters (see Fig. 3). On the other hand, only scarce
differences between the three recording days were found in
CA-Y and CA-P.
Attending to atopic status: Patients classified as atopic
presented significantly decreased ℘ in R3 with respect to R2
from 02 to 03 a.m. In the case of non-atopic subjects, they
presented decreased ℘ in R3 when compared with R1 at 01
and from 05 to 06 a.m., and in R2 with respect to R1 at 05 a.m,
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TABLE I
MEDIAN OF THE MOST RELEVANT HEART RATE VARIABILITY PARAMETERS OBTAINED FROM A TWO-HOUR WINDOW CENTERED AT 04 A.M. RESULTS
FOR EACH RECORDING DAY ATTENDING TO THEIR CURRENT ASTHMA STATUS, ATOPY AND RESPONSE TO TREATMENT ARE DISPLAYED. STATISTICAL
SIGNIFICANT DIFFERENCES WITH R1 ARE INDICATED WITH * (P ≤ 0.05), WHEREAS DIFFERENCES WITH R2 ARE LABELED WITH † (P ≤ 0.05).
STATISTICAL DIFFERENCES AFTER BONFERRONI CORRECTION (P ≤ 0.017) ARE LABELED AS ** OR ‡.
NN (ms) RMSSD (ms) PHF (ad ×10−3) PLFn (n.u.) ℘ (n.u.)
R1 R2 R3 R1 R2 R3 R1 R2 R3 R1 R2 R3 R1 R2 R3
Attending to asthma:
• CA-N 743.9 695.5 671.5† 67.41 58.96 42.39∗,† 2.86 2.85 1.53∗,‡ 0.35 0.39 0.45‡ 0.39 0.40 0.34‡
• CA-P 731.8 696.5 686.4 86.26 62.33 74.56 4.20 2.86 2.53 0.39 0.42 0.44 0.38 0.37 0.40
• CA-Y 703.7 748.0 714.4 79.43 87.41 64.33 3.05 4.64 2.93 0.34 0.33 0.35 0.38 0.39 0.40
Attending to SPT:
• Non-atopic 715.9 696.5 684.0 69.01 58.96 59.74 2.96 2.48 2.14 0.43 0.40 0.44 0.36 0.40 0.38
• Atopic 772.0 743.0 708.8 96.80 94.39 83.88 5.14 5.64 4.46 0.30 0.32 0.34 0.38 0.38 0.39
Attending to treatment:
• No effective 744.9 695.5 701.5 86.26 58.20 58.39 4.34 2.83 2.27 0.42 0.39 0.47 0.35 0.36 0.33
• Partially effective 709.2 670.5 670.1 51.30 45.07 34.80 2.22 1.66 0.98 0.32 0.42 0.43 0.39 0.41 0.40
• Effective 722.0 731.3 711.3 81.59 79.82 78.77 3.54 4.52 3.09 0.35 0.33 0.36 0.38 0.38 0.38
TABLE II
MEDIAN OF THE CARDIORESPIRATORY COUPLING PARAMETERS
OBTAINED FROM A TWO-HOUR WINDOW CENTERED AT 04 A.M. RESULTS
FOR EACH RECORDING DAY ATTENDING TO THEIR CURRENT ASTHMA
STATUS, ATOPY AND RESPONSE TO TREATMENT ARE DISPLAYED.
STATISTICAL SIGNIFICANT DIFFERENCES WITH R2 ARE INDICATED WITH




R1 R2 R3 R1 R2 R3
Attending to asthma:
• CA-N 0.087 0.089 0.082‡ 0.909 0.911 0.907
• CA-P 0.088 0.087 0.086 0.912 0.911 0.910
• CA-Y 0.088 0.091 0.086 0.912 0.913 0.911
Attending to SPT:
• Non-atopic 0.087 0.089 0.082 0.911 0.911 0.910
• Atopic 0.087 0.088 0.090 0.910 0.913 0.912
Attending to treatment:
• No effective 0.076 0.080 0.082 0.906 0.905 0.907
• Partially effective 0.087 0.089 0.082† 0.910 0.911 0.912
• Effective 0.088 0.089 0.087 0.912 0.912 0.911
and increased PLFn in R3 with respect to R1 at 05 a.m. Finally,
a tendency towards decreased Ω and γ̂2
Ω
was assessed in R3
with respect to R2 and R1, turning statistically significant for
Ω from 23 to 01 a.m.
Attending to the response to treatment: Statistically
significant differences were only found in the group with
partial response to ICS treatment, being only noticeable in
PLFn, which was increased in R3 when compared with R1 at
05, and at 03 a.m. when compared with R2. Regarding the
CRC indexes, decreased Ω and γ̂2
Ω
were assessed in the group
with partial response to treatment from 01 to 03 and 02 a.m.
respectively. The same behavior was found at 00 a.m. in the
group which responded effectively to treatment.
IV. DISCUSSION
All the children underwent the same ICS treatment during
three months. However, whereas ANS activity (as measured
from HRV) remained unchanged after treatment completion
in those children classified as CA-Y, a decrease in parasym-
pathetic activity and an increase in sympathetic dominance
was observed in the CA-N group. Since previous studies have
assessed an augmented vagal activity in asthmatics [15], [18],
[19], the lowered PNS activity in CA-N following treatment
could be reflecting recovery from illness, so that vagal over-
activity is gradually diminished towards homeostatic levels.
Also a reduction in ℘ and CRC (as meadured from Ω and
γ̂2
Ω
) were assessed in this group. Since CRC is related to how
the respiratory activity modulates the HR, a reduction in CRC
measurements and ℘ could be reflecting a less synchronous
vagal modulation of respiratory and cardiac rhythms or a less
regular PNS activity, respectively. In this case, the interpreta-
tion might be linked to the concept of illness as a state of
reduced complexity [42], [43], suggesting that HRV might
be more dependent on the respiratory activity in asthma or
in subjects at an increased risk of developing asthma in the
future. The fact that both Ω and γ̂2
Ω
were lowered in R3 in
the CA-N group suggests a reduction in the frequency span in
which HRV is governed by respiration, but also in the strength
of the interdependence of cardiac and respiratory control in
those subjects that have overcome the disease. This hypothesis
is supported by previous studies suggesting lowered chaoticity
and regularity of impedance pneumography [44] and airflow
pattern [45] in subjects with a worse asthma outcome. It is
noteworthy that, in concordance with our previous work [20],
most significant differences were obtained between 02 and 04
a.m., thus when airway function is lowest [25], [46]. Regarding
the CA-P group, only scarce differences in ANS activity were
assessed, which could reflect an intermediate behavior between
those of CA-N and CA-P.
Despite not being specific for asthma, the presence of atopy
enhances the probability that a patient with respiratory symp-
toms presents allergic asthma [1], and it has been included
as a factor for the prediction of asthma in, e.g., the Isle of
Wight study [47]. For these reasons, we analyzed the results
regarding the atopic status of the patients. Although a reduced
CRC was assessed in R3 in the non-atopic group, the fact that
not consistent differences were found in the other considered
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Fig. 3. Boxplots corresponding to some of the analyzed parameters in R1 (black), R2 (dark gray) and R3 (light gray) attending to the current asthma status.
Each box corresponds to a two-hour window centered in the hour depicted in the figure (although boxes with the same time reference are depicted separately
for clarity, same central hour was considered in the analysis). Medians of the boxes corresponding to the same measurement day are connected with solid
lines, and statistical significant differences are labeled with * (p ≤ 0.05). Statistical differences after Bonferroni correction (p ≤ 0.017) are labeled as **.
PHF, as obtained from m(n), is adimensional (ad).
indexes suggests that atopy is not closely related with the
apparent altered ANS activity in CA-Y.
On the other hand, whereas changes in ANS function were
expected to be produced by a proper response to ICS treatment,
no differences were found in the HRV parameters of the
group for which treatment resulted effective (which constitutes
the majority of the dataset). However, small differences were
found in the group with partial response to treatment, specially
in the CRC. The most likely explanation for this outcome is
that most of the children for which the treatment was effective
were classified as CA-Y or CA-P, whereas the group with
partial response to ICS is mainly formed by subjects classified
as CA-N (Fig. 1), thus suggesting that the observed differences
may not be related with the treatment but with the evolution
of the illness itself. This result is specially interesting, as it
could indicate that, despite ICS treatment which is aimed to
reduce airway inflammation, altered ANS behavior might be
still present in the groups with a worse asthma prognosis.
The main limitation of this work resides in the absence of
polysomnographic recordings, so that it was not possible to
look for differences in HRV along the various sleep stages.
In order to deal with this restriction, we proposed to calculate
two-hour medians of the analyzed indexes to cover at least
one complete sleep cycle [41]. The fact that respiratory rate
is higher in children than in adults can also compromise the
traditional HRV analysis, with an upper bound of the HF band
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that results insufficient for an accurate measurement of the HF
power. In this way, the HF band was redefined adaptively in
function of the respiratory rate as already done in [20], where
also the methodology for dealing with the stronger effect of
RSA in children employed here was introduced.
In spite of the many studies stating the important role of
PNS as a source of the airway hyper-responsiveness character-
istic of asthma, the underlying mechanisms causing an abnor-
mal vagal activity have not been elucidated. The presence of
immune cells which are involved in the inflammatory response
has been considered as one likely explanation, as they release
inflammatory mediators that could alter local PNS activity and
trigger bronchial hyper-reactivity. However, several counter-
points can be highlighted. First, preventive treatment with anti-
inflammatory corticosteroids has been shown to be insufficient
for avoiding the development of asthma in young children [48].
Second, the presence of different phenotypes of asthma with
distinct manifestations and response to treatment, together with
an apparent absence of relationship between inflammation and
airway remodeling in children [49] suggest the existence of
other factors. Moreover, the fact that altered PNS activity in
asthmatics can be also noticed in HRV opposes to the idea of a
local effect. Fryer et al. suggested that excessive vagal stimu-
lation could be caused by a dysfunction of the M2 muscarinic
receptors [50], which are largely present in the post-ganglionic
nerves innervating the airways and provide negative feedback
in response to acetylcholine (ACh) withdrawal, thus inhibiting
the further release of ACh. Altought the lowered control over
ACh release might explain the increased vagal dominance
observed through HRV in the presence of asthma, as well as
the more regular PNS activity suggested by increased ℘ , if
cardiac vagal fibers also presented M2 receptors dysfunction,
the simultaneous reduction in the adaptability of cardiac and
respiratory vagal control due to excessive ACh release could
resemble an increased CRC. In this way, further research
is needed to completely understand the neural control in
asthmatics.
V. CONCLUSION
HRV analysis has been presented as a suitable non-invasive
tool for the assessment of abnormal ANS activity in children
at risk of asthma. The main outcome of this work is that vagal
activity and cardiorespiratory coupling, measured in a group
of children with obstructive bronchitis, were reduced after ICS
treatment in the subgroup at lower risk of asthma, whereas it
kept unchanged in those who presented a worse prognosis.
The difficulties of young children to perform repeatable spiro-
metric tests together with the lack of collaboration and the
low adherence to ICS treatment emphasize the interest in a
continuous monitoring of asthma in order to detect or predict
exacerbations, thus providing an objective measurement of the
evolution of the disease. In this way, HRV stands out as a
feasible option. In addition, the possibility of a continuous
monitoring of ANS activity in asthmatics could shed some
light on the physiological mechanisms underlying asthma, and
hence be useful for patient phenotyping, which constitutes the
first step towards personalized treatment.
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